company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3261000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3261000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3261000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1135000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1135000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2126000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,65000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-46000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2080000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,735000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1345000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1345000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1345000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22320000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22326000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q2,2010-04-01,2010-06-30,2011-08-12 16:31:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17343000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17343000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17343000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1433000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1433000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15910000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,28000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,56000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15938000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-515000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16453000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16453000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16453000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4464000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.69
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4466000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.68
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4500000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2010.0,Q3,2010-07-01,2010-09-30,2011-11-14 16:30:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.69
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,62000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,62000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,62000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1271000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4203000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5474000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5412000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-33000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5445000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5445000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5445000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5445000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-95.77
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-95.77
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q1,2011-01-01,2011-03-31,2012-05-09 07:55:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-95.77
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,105000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,134000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,239000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,239000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2007000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3619000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5626000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5387000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-8000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-165000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-173000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5560000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5560000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5560000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5560000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-75.14
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-75.14
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q2,2011-04-01,2011-06-30,2012-08-03 08:02:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-75.14
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,88000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,96000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,184000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,184000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2627000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4376000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7003000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6819000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-20000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6823000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6823000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6823000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6823000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,100000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-92.21
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,100000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-92.21
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 09:16:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-92.21
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1530000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,84000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1614000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1614000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3363000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5148000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,504000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9015000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7401000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-1000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-76000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-77000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7478000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7478000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7478000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7478000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2950000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.53
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2950000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.53
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2950000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.53
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2341000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,56000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2397000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2397000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2920000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6146000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,686000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9752000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7355000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7353000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7353000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7353000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7353000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,20744000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.35
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,20744000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.35
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,20774000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q1,2012-01-01,2012-03-31,2013-05-07 16:28:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.35
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2249000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2249000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2249000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3887000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7913000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,675000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12475000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10226000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10223000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10223000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10223000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10223000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,21284000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.48
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,21284000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.48
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,21284000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q2,2012-04-01,2012-06-30,2013-08-07 16:49:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.48
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5428000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5428000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5428000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4244000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10379000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,994000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15617000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10189000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10182000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10182000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10182000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10182000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,23825000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,23825000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,23825000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q3,2012-07-01,2012-09-30,2013-11-04 06:52:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4936000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-56000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4880000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4880000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6345000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12909000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,877000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20131000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15251000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,60000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,60000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15191000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15191000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15191000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15191000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,22579000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.67
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,22579000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.67
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,22579000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.67
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5118000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5118000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5118000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5654000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13338000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,699000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19691000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14573000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,89000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,89000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14484000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14484000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14484000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14484000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,26826000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.54
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,26826000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.54
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26826000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 16:33:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.54
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3413000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3413000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3413000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6443000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18454000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,706000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25603000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22190000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,83000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,83000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22107000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22107000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22107000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22107000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27280000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.81
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27280000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.81
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27280000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q2,2013-04-01,2013-06-30,2014-07-31 06:12:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.81
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1369000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1369000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1369000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6597000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22676000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,292000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29565000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28196000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,73000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,73000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28123000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28123000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28123000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28123000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27491000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.02
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27491000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.02
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27491000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q3,2013-07-01,2013-09-30,2014-10-30 16:18:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.02
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3474000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3474000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3474000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8866000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25176000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,376000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34418000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30944000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,97000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,159000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,256000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30688000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,48000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30736000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30736000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30736000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28087000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.09
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28087000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.09
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28087000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.09
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1586000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1586000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1586000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9804000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27868000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,390000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38062000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36476000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,75000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,70000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36406000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36424000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36424000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-36424000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31338000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.16
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,31338000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.16
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,31338000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q1,2014-01-01,2014-03-31,2015-04-30 16:15:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.16
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2343000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2343000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2343000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12591000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39528000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,537000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52656000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-50313000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,98000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,89000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-50224000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50240000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50240000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50240000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33057000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.52
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33057000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.52
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33057000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q2,2014-04-01,2014-06-30,2014-07-31 06:12:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.52
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1326000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1326000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1326000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14441000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34605000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,318000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49364000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-48038000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,47000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-312000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-265000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-48303000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-48319000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48319000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-48319000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33173000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.46
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33173000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.46
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33173000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q3,2014-07-01,2014-09-30,2014-10-30 16:18:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.46
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1237000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1237000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1237000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,17662000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40637000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,244000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,58543000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-57306000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,43000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,88000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,131000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-57175000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,490000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-57665000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-57665000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-57665000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32719000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.75
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32719000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.75
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32719000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.75
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,927000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,927000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,927000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,21671000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38207000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,222000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60100000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-59173000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,83000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-252000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-169000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59342000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,259000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59601000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59601000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59601000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36495000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.63
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36495000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.63
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36495000.0
Synageva BioPharma Corp ,GEVA,,0000911326,2015.0,Q1,2015-01-01,2015-03-31,2015-04-30 16:15:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.63
